ADC startup DualityBio seeks Hong Kong IPO amid precarious market
Multi-partnered ADC startup Duality Biologics is moving forward with its initial public offering plans on the Hong Kong Stock Exchange (HKEX).
DualityBio expects to get …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.